Newsroom

Sorted by: Latest

-

Sinda Ltd. Announces Launch of its Initial Public Offering

NEW YORK--(BUSINESS WIRE)--Sinda Ltd. (the "Company" or "Sinda”) today announced the launch of the roadshow for its initial public offering (“IPO”) of 17,750,000 shares of its common stock. In connection with the offering, Sinda expects to grant the underwriters a 30-day option to purchase up to 2,662,500 shares of common stock. The IPO price is expected to be between $11.25 and $13.25 per share. Sinda's common stock has been approved for listing, subject to official notice of issuance, under t...
-

First Trust Global Funds PLC UK Regulatory Announcement: Net Asset Value(s)

LONDON--(BUSINESS WIRE)--  Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share First Trust Indxx Global Aerospace & Defence UCITS ETF 19.06.2026 MISL.LN IE000NVDQXE1 3,950,002.00 USD 136,233,427.39 34.490  ...
-

First Trust Global Funds PLC UK Regulatory Announcement: Net Asset Value(s)

LONDON--(BUSINESS WIRE)--  Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share First Trust Vest US Equity Max Buffer UCITS ETF - March 19.06.2026 MMAR.LN IE0002PPCMH6 50,002.00 USD 1,330,078.51 26.601  ...
-

British Crews Join Italy’s round‑the‑coast Marina Militare Nastro Rosa Tour 2026

VENICE, italy--(BUSINESS WIRE)--Three British teams are taking part in the 6th edition of the Marina Militare Nastro Rosa Tour 2026 – the Round-Italy Sailing Race that started on 4 June from Venice and will finish on 12 July in Genoa, after covering 1,250 nautical miles around Italy and calling at 9 stages. The competition is organised by Difesa Servizi, the in‑house company of the Italian Ministry of Defence, in collaboration with the Italian Navy and SSI Sport & Events, a sports marketing...
-

First Trust Global Funds PLC UK Regulatory Announcement: Net Asset Value(s)

LONDON--(BUSINESS WIRE)--  Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share First Trust Bloomberg Nuclear Power UCITS ETF 19.06.2026 RCTR.LN IE000J5PESP7 150,002.00 USD 2,831,241.83 18.875  ...
-

Pacific Defense Launches Dual-Enclave 100G Ethernet Switch for Secure Multi-Mission C5ISR and Electronic Warfare Systems

EL SEGUNDO, Calif.--(BUSINESS WIRE)--Pacific Defense today announced the launch of the SWH1530VP, a next-generation dual-enclave 100/40 Gigabit Ethernet switch engineered to provide secure, deterministic, and high-performance networking for modern Command, Control, Communications, Computers, Cyber, Intelligence, Surveillance, Reconnaissance (C5ISR), Electronic Warfare (EW), and edge computing applications. Aligned with SOSA™, CMOSS, and OpenVPX™ standards, the 3U VPX module combines advanced La...
-

iCapital® and UMB Expand Blockchain-Enabled Network for Alternative Investments Through Distributed Ledger Technology Integration

NEW YORK & KANSAS CITY, Mo.--(BUSINESS WIRE)--iCapital1, the global fintech company shaping the future of investing, today announced an integrated partnership with UMB Fund Services (UMBFS), a subsidiary of UMB Financial Corporation (NASDAQ: UMBF) and a national leader in registered and alternative investment fund administration services, to further expand the deployment of its distributed ledger technology (DLT) into the operating layer of fund administration. This collaboration extends iCapit...
-

TWO Urges Stockholders to Vote FOR the CCM Transaction Today; Failure to Approve Risks a Significant Decline in TWO’s Stock Price

NEW YORK--(BUSINESS WIRE)--TWO Urges Stockholders to Vote FOR the CCM Transaction Today; Failure to Approve Risks a Significant Decline in TWO’s Stock Price...
-

The Winn-Dixie Company completes final Harveys Supermarket conversions, uniting stores under one iconic banner

JACKSONVILLE, Fla.--(BUSINESS WIRE)--The Winn-Dixie Company completes final Harveys Supermarket conversions, uniting stores under one iconic banner...
-

Syntax Bio, Ajinomoto Health & Nutrition North America, Inc. Collaborate to Evaluate Stem Cell Culture Technologies Using Cellgorithm™ Platform

CHICAGO & ITASCA, Ill.--(BUSINESS WIRE)--Syntax Bio, a synthetic biology company programming the next generation of cell therapies, and Ajinomoto Health & Nutrition North America, Inc. (AHN), a leader in amino acid science and cell culture innovation and part of Ajinomoto Group, today announced a collaboration to evaluate Ajinomoto Group’s StemFit™ stem cell culture products using Syntax Bio’s proprietary Cellgorithm™ platform. Through the collaboration, AHN is providing Syntax Bio with Ste...